Riskpilot← Back to searchSign inGet full accessF Heartmed AB
ABActiveOrg 5568459928Skyttens Väg 4Medical specialists activities · NACE 8622Est. 20110 employees
Revenue 2024
SEK 644K
-10% vs 2023
EBITDA margin
86.4%
-15% vs 2023
Equity ratio
89.1%
Financial strength
Net profit 2024
SEK 500K
-7% vs 2023
| Revenue | SEK 644K | -10% |
| EBITDA | SEK 556K | -15% |
| Net profit | SEK 500K | -7% |
| Total assets | SEK 2,8M | +19% |
| Equity | SEK 2,5M | +25% |
| Employees | 0 | — |
Legal name
F Heartmed AB
Org number
5568459928
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 mars 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget bedriver en läkareverksamhet, bemanningsverksamhet, och Restaurangverksamhet
Address
Skyttens Väg 4
Phone
+46737418777
Email
drmier2009@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 30 | 578 | 608 | 714 | 644 |
| Staff expenses | — | — | −26 | −20 | −19 |
| EBITDA | 18 | 536 | 547 | 651 | 556 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 18 | 536 | 547 | 651 | 556 |
| Net financials | — | −1 | 2 | 23 | 73 |
| Profit before tax | 17 | 535 | 549 | 675 | 630 |
| Tax | −4 | −110 | −115 | −139 | −129 |
| Net profit | 13 | 425 | 434 | 536 | 500 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 375 | 1 856 | 2 160 | 2 399 | 2 844 |
| Equity | 1 289 | 1 713 | 1 898 | 2 034 | 2 534 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 87 | 142 | 263 | 365 | 310 |
| Total debt | 87 | 142 | 263 | 365 | 310 |
EBITDA margin
86.4%
This company
15.8%
Market median
+447% vs market
20202024
Equity ratio
89.1%
This company
38.2%
Market median
+133% vs market
20202024
Return on equity
19.7%
This company
18.4%
Market median
+7% vs market
20202024
Net profit margin
77.7%
This company
8.1%
Market median
+859% vs market
20202024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of F Heartmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Faysal Mier Miersson | Chief Executive Officer | 0 companies |
| Shlair Mir Kaky | Deputy Board Member | 0 companies |